A02BD08
Poland-
Pylera
Form: capsules, hard
Active substance Dosage Bismuth potassium subcitrate 140 mg Metronidazole 125 mg Tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvisé Pharmaceuticals
-
Pylera
Form: capsules, hard
Active substance Dosage Bismuth potassium subcitrate 140 mg Metronidazole 125 mg Tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Allergan Pharmaceuticals International Limited
-
Pylera
Form: capsules, hard
Active substance Dosage Bismuth potassium subcitrate 140 mg Metronidazole 125 mg Tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals
-
Pylera
Form: capsules, hard
Active substance Dosage Bismuth potassium subcitrate 140 mg Metronidazole 125 mg Tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals
-
Pylera
Form: capsules, hard
Active substance Dosage Bismuth potassium subcitrate 140 mg Metronidazole 125 mg Tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals
-
Pylera
Form: capsules, hard
Active substance Dosage Bismuth potassium subcitrate 140 mg Metronidazole 125 mg Tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals
-
Pylera
Form: capsules, hard
Active substance Dosage Bismuth potassium subcitrate 140 mg Metronidazole 125 mg Tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals
-
Pylera
Form: capsules, hard
Active substance Dosage Bismuth potassium subcitrate 140 mg Metronidazole 125 mg Tetracycline hydrochloride 125 mg ATC code: A02BD08
Manufacturer: Laboratoires Juvise Pharmaceuticals